Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-066686
Filing Date
2025-07-09
Accepted
2025-07-09 16:03:09
Documents
1
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2520236-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2520236-3_4seq1.xml 4 3339
  Complete submission text file 0001104659-25-066686.txt   4913
Mailing Address C/O NYSE EURONEXT 11 WALL STREET NEW YORK NY 10005
Business Address
GELTZEILER MICHAEL S (Reporting) CIK: 0001182139 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 251113620

Mailing Address 23461 SOUTH POINTE DRIVE, SUITE 390 LAGUNA HILLS CA 92653
Business Address 23461 SOUTH POINTE DRIVE, SUITE 390 LAGUNA HILLS CA 92653 833-393-6684
HYPERION DEFI, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)